Related Experiment Videos

Evaluation of dose-response curve analysis in delineating shared or different molecular sites of action for

Douglas A Dawson1, Brenda D Scott, M Jason Ellenberger

  • 1Department of Biology/Toxicology, Ashland University, Ashland, OH 44805, USA.

Insights

This study used frog embryo toxicity tests to determine if chemicals act on the same molecular sites. Results suggest dose-response curve analysis can identify shared toxic mechanisms for combined chemical effects.

Area of Science:

  • Environmental toxicology
  • Molecular toxicology
  • Developmental toxicology

Background:

  • Assessing combined chemical toxicity is challenging due to diverse molecular sites of action.
  • Osteolathyrogens provide a model to study chemicals inhibiting connective tissue fiber cross-linking.
  • Understanding shared toxic mechanisms is crucial for predicting mixture toxicity.

Purpose of the Study:

  • To evaluate the utility of frog embryo concentration-response curves for identifying shared molecular sites of toxic action.
  • To compare in vitro cofactor reactivity with in vivo toxicity of osteolathyrogens.
  • To test the hypothesis that agents with similar sites of action exhibit dose-additive effects.

Main Methods:

  • Frog embryo toxicity assays (96-h) and UV-VIS spectrophotometry were employed.
  • Concentration-response curves for single chemicals and mixtures were generated.
  • Statistical analysis compared theoretical dose-addition curves with experimental mixture data.

Main Results:

  • Combinations of cofactor-binding osteolathyrogens showed dose-additive effects, consistent with shared molecular sites.
  • Agents lacking rapid cofactor binding did not exhibit predictable dose-additive toxicity.
  • Dose-response curve slopes and EC50 values supported the hypothesis for shared action.

Conclusions:

  • Dose-response curve analysis is a valuable tool for distinguishing common versus different molecular sites of toxic action.
  • The described methodology can elucidate the mechanistic basis of combined toxicant effects.
  • Further research is warranted to refine these approaches for mixture toxicity assessment.

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...